Pilot study into the effectiveness of neurofeedback as a treatment for major depressive disorder

Completed

• Conditions: depression; major depressive disorder

• Registration Number: NL-OMON33576
• Lead Sponsor: Academisch Ziekenhuis Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

major depressive episode

Exclusion Criteria

- history of brain trauma
- current use of antipsychotics, moodstabilisers, or benzodiazepines. current use of antidepressants is allowed if type and dosage are not changed during the study
- chronic depression (>2 years)
- dysthymia
- bipolar disorder
- lefthandedness
- severe depression or suicidality (HDRS >25)
- pregnancy
- other comorbid axis 1 disorders other than anxiety disorders or a personality disorder

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>- Quick Inventory of Depressive Symptoms (QIDS)<br /><br>- Hamilton Depression Rating Scale (HDRS)<br /><br>- decrease of alpha-asymmetry</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>- Positive and Negative Affect Schedule (PANAS)<br /><br>- Temporal Experience of Pleasure Scale (TEPS)<br /><br>- Heartrate variability</p><br>